TOPK Inhibitor HI-TOP-32 Administration in DEN-induced Hepatocarcinogenesis in C57bl/6 Mice Results in Tumour Regression
HPB - United Kingdom
doi 10.1016/j.hpb.2016.02.366
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Elsevier BV